25-Hydroxyvitamin D3 1α-hydroxylase splice variants in benign and malignant ovarian cell lines and tissue

Anticancer Research

Volumn 29, Issue 9, 2009, Pages 3627-3633

  Fischer, Dorothea ^a   Thomé, Marlene ^a   Becker, Stefh ^a   Cordes, Tim ^a   Diedrich, Klaus ^a   Friedrich, Michael ^b   Thill, Marc ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

1 hydroxylase; COV 434; GLZ; HGL5; Ovarian cancer; Splice variants; Vitamin D3

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; RNA; MESSENGER RNA; PRIMER DNA;

BENIGN TUMOR; CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ARTICLE; CYTOLOGY; ENZYMOLOGY; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE; OVARY; OVARY TUMOR; PATHOLOGY; RNA SPLICING;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; BASE SEQUENCE; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; OVARY; POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER;

EID: 68549122662     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF and Hayes RB; Prostate, Lung, Colorectal, and Ovarian Trial Project Team: Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16(12): 2623-2630, 2007.
2. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY and Goodman MT: Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 16(12): 2566-2571, 2007. (Pubitemid 351196310)
3. Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P and Lundin E: Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 260(1-2): 209-215, 2008.
4. Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW and Hankinson SE: Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(4): 783-788, 2007. (Pubitemid 46650582)
5. Colston KW and Hansen CM: Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9: 45-59, 2002.
6. 3-24-hydroxylase in rat osteoblasts. Endocrinology 134: 1794-1799, 1994. (Pubitemid 24110739)
7. 3-1α-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103: 316-321, 2007. (Pubitemid 46420518)
8. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W and Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164: 239-246, 2003.
9. Johnson CS, Muindi JR, Hershberger PA and Trump DL: The antitumor efficacy of calcitriol: preclinical studies. Anticancer Res 26: 2543-2550, 2006.
10. Zhang X, Nicosia SV and Bai W: Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets 6(3): 229-244, 2006. (Pubitemid 43764742)
11. Zehnder D, Bland R, Williams MC, Mc Ninch RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of 25-hydroxyvitamin D(3)-1α-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
12. 3 1α-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10. Cancer Genom Proteom 4: 295-300, 2007. (Pubitemid 46814251)
13. Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K and Narvaez CJ: Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 133: 2425-2433, 2003. (Pubitemid 36828849)
14. Hewison M, Zehnder D, Bland R and Stewart PM: 1α-Hydroxylase and the action of vitamin D. J Mol Endocrinol 25: 141-148, 2000.
15. Hewison M, Zehnder D, Chakraverty R and Adams JS: Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Mol Cell Endocrinol 215: 31-38, 2004. (Pubitemid 38333240)
16. 3 growth response of Ovcar-33 ovarian cancer cells. Int J Cancer 108: 367-373, 2004. (Pubitemid 37549601)
17. Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ and Hewison M: Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 11: 3579-3586, 2005. (Pubitemid 40627915)
18. Friedrich M, Diesing D, Cordes T, Fischer D, Becker S, Chen TC, Flanagan JN, Tangpricha V, Gherson I, Holick MF and Reichrath J: Analysis of 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant breast tissue. Anticancer Res 26: 2615-2620, 2006. (Pubitemid 44155542)
19. Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S and Zeillinger R: Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 8: 2253-2259, 2002. (Pubitemid 34753598)
20. Adams M, Jones JL, Walker RA, Pringle JH and Bell SC: Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res 62(11): 3289-3297, 2002. (Pubitemid 34602427)
21. Becker S, Cordes T, Diesing D, Diedrich K and Friedrich M: Expression of 25 hxdroxyvitamin D3-1α-hydroxylase in human endometrial tissue. J Steroid Biochem Mol Biol 103(3-5): 771-775, 2007. (Pubitemid 46401334)
22. Radermacher J, Diesel B, Seifert M, Tilgen W, Reichrath J, Fischer U and Meese E: Expression analysis of CYP27B1 in tumor biopsies and cell cultures. Anticancer Res 26: 2683-2686, 2006. (Pubitemid 44155549)
23. Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, Reichrath J, Fischer U and Meese E: Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res 11: 5370-5380, 2005. (Pubitemid 41060810)
24. 3 1α-hydroxylase in brain and skin cancer. J Steroid Biochem Mol Biol 89-90(1-5): 527-532, 2004. (Pubitemid 38844342)
25. Maas RM, Reus K, Diesel B, Steudel WI, Feiden W, Fischer U and Meese E: Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,α-hydroxylase (CYP 27B1) in human malignant glioma. Clin Cancer Res 7: 868-875, 2001. (Pubitemid 32708723)
26. 3 production. Endocrinology 148(7): 3410-3418, 2007. (Pubitemid 46997000)
27. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method 4: 402-408, 2001. (Pubitemid 34164012)
28. Hsu JY, Feldman D, McNeal JE and Peehl DM: Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res 61(7): 2852-2856, 2001. (Pubitemid 32691924)
29. De Rosa M, Morelli G, Cesaro E, Duraturo F, Turano M, Rossi GB, Delrio P and Izzo P: Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript. Gene 395(1): 8-14, 2007. (Pubitemid 46670630)
30. Ahonen MH, Zhuang YH, Aine R, Ylikomi T and Tuohimaa P: Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 86: 40-46, 2000. (Pubitemid 30133984)
31. 3 down-regulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 263(1-2): 55-64, 2007. (Pubitemid 44828231)
32. Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R and Cross HS: Clonal differences in expression of 25-hydroxyvitamin D(3)-1α-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1α,25-dihydroxyvitamin D(3). Exp Cell Res 276(2): 320-327, 2002.
33. Ogunkolade BW, Boucher B, Fairclough PD, Hitman GA, Dorudi S, Jenkins PJ and Bustin SA: Expression of 25-hydroxyvitamin D-1α-hydroxylase mRNA in individuals with colorectal cancer. Lancet 359(9320): 1831-1832, 2002.
34. Busi F and Crested T: CYP3A5 mRNA degradation by nonsense- mediated mRNA decay. Mol Pharmacol 68(3): 808-815, 2005. (Pubitemid 41206036)
35. Anderson MG, Nakane M, Ruan X, Kroeger PE and Wu-Wong JR: Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol 57: 234-240, 2006. (Pubitemid 41779843)
36. Audo I, Darjatmoko SR, Schlamp CL, Lokken JM, Lindstrom MJ, Albert DM and Nickells RW: Vitamin D analogues increase p53, p21 and apoptosis in a xenograft model of human retinoblastoma. Invest Ophtalmol Vis Sci 44: 4192-4199, 2003. (Pubitemid 37186250)
37. Trump DL, Muindi J, Fakih M, Yu W-D and Johnson CS: Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Res 26: 2551-2556, 2006. (Pubitemid 44155534)
38. Altschul SF, Gish W, Myers EW and Lipman DJ: Basic local alignment search tool. J Mol Biol 215(3): 403-410, 1990. (Pubitemid 20364473)